Clinical features and diagnosis of hairy cell leukemia

被引:19
作者
Quest, Graeme R. [1 ]
Johnston, James B. [2 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Univ Manitoba, Hematol Oncol Sect, CancerCare Manitoba, Winnipeg, MB, Canada
关键词
Hairy cell leukemia; Clinical features; Diagnosis; Immunophenotyping; BRAF V600E; BONE-MARROW; T-CELLS; HEMOLYTIC-ANEMIA; BRAF MUTATIONS; EXPRESSION; DISEASE; LESIONS; COMPLICATIONS; MARKER; RETICULOENDOTHELIOSIS;
D O I
10.1016/j.beha.2015.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Significant advances in the diagnosis and treatment of hairy cell leukemia (HCL) have recently been made. Improved distinction of HCL from its mimics though clinical presentations, morphologic and immunophenotypic features, and more recently molecular biology, has highlighted marked differences in treatment response and overall prognosis between these disorders. As our understanding of the unique pathobiology of HCL has grown, exciting new avenues of treatment as well as insight into immune function have been obtained. This review provides an overview of the clinical features and diagnostic attributes of HCL, with contrast to other mature B cell lymphoproliferative disorders with overlapping features. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:180 / 192
页数:13
相关论文
共 84 条
  • [1] Application of a BRAF V600E Mutation-specific Antibody for the Diagnosis of Hairy Cell Leukemia
    Andrulis, Mindaugas
    Penzel, Roland
    Weichert, Wilko
    von Deimling, Andreas
    Capper, David
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (12) : 1796 - 1800
  • [2] [Anonymous], N ENGL J MED
  • [3] SPECIFIC SKIN-LESIONS AS THE PRESENTING SYMPTOM OF HAIRY-CELL LEUKEMIA
    ARAI, E
    IKEDA, S
    ITOH, S
    KATAYAMA, I
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (04) : 459 - 464
  • [4] ARKEL YS, 1984, CANCER-AM CANCER SOC, V53, P2401, DOI 10.1002/1097-0142(19840601)53:11<2401::AID-CNCR2820531106>3.0.CO
  • [5] 2-R
  • [6] Recurrent BRAF mutations in Langerhans cell histiocytosis
    Badalian-Very, Gayane
    Vergilio, Jo-Anne
    Degar, Barbara A.
    MacConaill, Laura E.
    Brandner, Barbara
    Calicchio, Monica L.
    Kuo, Frank C.
    Ligon, Azra H.
    Stevenson, Kristen E.
    Kehoe, Sarah M.
    Garraway, Levi A.
    Hahn, William C.
    Meyerson, Matthew
    Fleming, Mark D.
    Rollins, Barrett J.
    [J]. BLOOD, 2010, 116 (11) : 1919 - 1923
  • [7] Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL)
    Baseggio, L.
    Traverse-Glehen, A.
    Callet-Bauchu, E.
    Morel, D.
    Magaud, J. P.
    Berger, F.
    Salles, G.
    Felman, P.
    [J]. HEMATOLOGICAL ONCOLOGY, 2011, 29 (01) : 47 - 51
  • [8] LEUKEMIC RETICULOENDOTHELIOSIS
    BOURONCLE, BA
    WISEMAN, BK
    DOAN, CA
    [J]. BLOOD, 1958, 13 (07) : 609 - 630
  • [9] BOURONCLE BA, 1979, BLOOD, V53, P412
  • [10] BURKE JS, 1984, SEMIN ONCOL, V11, P334